CI
Conning Inc Portfolio holdings
AUM
$2.91B
This Quarter Return
+1.66%
1 Year Return
+12.27%
3 Year Return
+38.61%
5 Year Return
+77.33%
10 Year Return
+147.58%
AUM
$2.99B
AUM Growth
+$2.99B
(-2.8%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-3.38%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
384
New
10
Increased
60
Reduced
215
Closed
13
Top Buys
| 1 |
Paychex
PAYX
|
$36.7M |
| 2 |
Pfizer
PFE
|
$6.43M |
| 3 |
Automatic Data Processing
ADP
|
$5.71M |
| 4 |
EOG Resources
EOG
|
$5.27M |
| 5 |
CVS Health
CVS
|
$5.09M |
Top Sells
| 1 |
Intel
INTC
|
$40M |
| 2 |
Eli Lilly
LLY
|
$33.5M |
| 3 |
Cigna
CI
|
$28.3M |
| 4 |
Analog Devices
ADI
|
$11.1M |
| 5 |
Philip Morris
PM
|
$9.57M |
Sector Composition
| 1 | Technology | 13.36% |
| 2 | Financials | 12.25% |
| 3 | Consumer Staples | 11.6% |
| 4 | Healthcare | 11.08% |
| 5 | Industrials | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Marathon Petroleum
MPC
$54.4B
| $754K | 0.03% |
5,591
-981
| -15% | -$132K |
|
177
Intuitive Surgical
ISRG
$158B
| $743K | 0.02% |
2,910
-386
| -12% | -$98.6K |
|
178
GE Aerospace
GE
$293B
| $735K | 0.02% |
9,633
-3,214
| -25% | -$245K |
|
179
Marsh & McLennan
MMC
$101B
| $701K | 0.02% |
4,208
-481
| -10% | -$80.1K |
|
180
IBM
IBM
$227B
| $700K | 0.02% |
5,341
-203
| -4% | -$26.6K |
|
181
Progressive
PGR
$145B
| $685K | 0.02% |
4,790
-175
| -4% | -$25K |
|
182
Williams Companies
WMB
$70.5B
| $682K | 0.02% |
22,847
-102
| -0.4% | -$3.05K |
|
183
PayPal
PYPL
$66.5B
| $650K | 0.02% |
8,553
-352
| -4% | -$26.7K |
|
184
iShares MSCI EAFE Growth ETF
EFG
$13.1B
| $640K | 0.02% |
6,830
| – | – |
|
185
Monster Beverage
MNST
$62B
| $622K | 0.02% |
11,520
-56
| -0.5% | -$3.03K |
|
186
Calamos Strategic Total Return Fund
CSQ
$2.97B
| $622K | 0.02% |
44,405
+981
| +2% | +$13.7K |
|
187
Boston Scientific
BSX
$159B
| $608K | 0.02% |
12,162
-69
| -0.6% | -$3.45K |
|
|
188
Cigna
CI
$80.2B
| $606K | 0.02% |
2,377
-111,156
| -98% | -$28.3M |
|
189
T-Mobile US
TMUS
$284B
| $601K | 0.02% |
4,146
-40
| -1% | -$5.79K |
|
190
Northrop Grumman
NOC
$83.2B
| $597K | 0.02% |
1,293
-203
| -14% | -$93.7K |
|
191
Zoetis
ZTS
$67.6B
| $581K | 0.02% |
3,492
-158
| -4% | -$26.3K |
|
192
CSX Corp
CSX
$60.2B
| $580K | 0.02% |
19,379
-2,553
| -12% | -$76.4K |
|
193
Becton Dickinson
BDX
$54.3B
| $571K | 0.02% |
2,307
-31,663
| -93% | -$7.84M |
|
194
Aon
AON
$80.6B
| $569K | 0.02% |
1,805
-90
| -5% | -$28.4K |
|
195
Southern Company
SO
$101B
| $566K | 0.02% |
8,136
-47
| -0.6% | -$3.27K |
|
196
Vertex Pharmaceuticals
VRTX
$102B
| $559K | 0.02% |
1,773
-20
| -1% | -$6.3K |
|
197
Humana
HUM
$37.5B
| $541K | 0.02% |
1,114
-178
| -14% | -$86.4K |
|
198
Fiserv
FI
$74.3B
| $539K | 0.02% |
4,771
-30
| -0.6% | -$3.39K |
|
199
Micron Technology
MU
$133B
| $539K | 0.02% |
8,930
-104
| -1% | -$6.28K |
|
200
Regeneron Pharmaceuticals
REGN
$59.8B
| $533K | 0.02% |
649
-7
| -1% | -$5.75K |
|